A Study to Evaluate the Safety and Efficacy of CNTX-6970 in Subjects With Knee Osteoarthritis Pain.

Completed · Phase 2 · Has a placebo group

Conditions studied: Knee Osteoarthritis

In brief

The primary objective of this study is to evaluate the safety and efficacy of CNTX-6970 for the treatment of pain related to OA of the knee compared to placebo. CNTX-6970 is being developed as a new treatment for chronic pain, including painful osteoarthritis of the knee.

Key facts

Study ID

NCT05025787

Run by

Maurizio Fava, MD

People needed

55

Starts

2021-10-25

Expected to finish

2024-06-11

Last updated by the study team

2025-11-26

Who can join

Age: 40 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of California San Diego — La Jolla, California, United States
• University of California- Davis — Sacramento, California, United States
• University of Florida — Gainesville, Florida, United States
• M&M Clinical Trials — Miami, Florida, United States
• Massachusetts General Hospital — Boston, Massachusetts, United States
• Healthcare Research Network — Hazelwood, Missouri, United States
• New York University Langone Health — New York, New York, United States
• Icahn School of Medicine at Mount Sinai — New York, New York, United States
• University of Rochester — Rochester, New York, United States
• Montefiore Medical Center — The Bronx, New York, United States
• Center for Clinical Research — Winston-Salem, North Carolina, United States
• University of Pennsylvania — Philadelphia, Pennsylvania, United States
• University of Pittsburgh — Pittsburgh, Pennsylvania, United States
• UTsouthwestern Medical Center — Dallas, Texas, United States
• University of Washington — Seattle, Washington, United States
• University of Wisconsin- Madison — Madison, Wisconsin, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.